Report cover image

Rx/Reimbursement Adult Incontinence in the Netherlands

Publisher Euromonitor International
Published Mar 07, 2025
Length 20 Pages
SKU # EP19813076

Description

Value sales of RX/reimbursement adult incontinence increased modestly in 2024, but negative volume growth continued to exert downward pressure on overall performance. Many consumers opted to purchase incontinence products through retail channels or e-commerce platforms rather than rely on reimbursed options. The primary reasons for this shift included the flexibility, discretion, and broader product variety available outside of the reimbursement system.

Euromonitor International's Rx/Reimbursement adult incontinence in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2020-2024, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2029 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

20 Pages
Rx/Reimbursement Adult Incontinence in the Netherlands
Euromonitor International
March 2025
List Of Contents And Tables
RX/REIMBURSEMENT ADULT INCONTINENCE IN THE NETHERLANDS
KEY DATA FINDINGS
2024 DEVELOPMENTS
Negative volume growth puts downward pressure on value
TENA remains the most significant player despite insurance contract limitations
Distribution confined to pharmacies and medical device specialists
PROSPECTS AND OPPORTUNITIES
Reselling unopened products may slow down market growth
Sustainability concerns drive further product innovation
Home delivery to dominate distribution as the population ages
CATEGORY DATA
Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2024-2029
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2024-2029
TISSUE AND HYGIENE IN THE NETHERLANDS
EXECUTIVE SUMMARY
Tissue and hygiene in 2024: The big picture
2024 key trends
Competitive landscape
Retail developments
What next for tissue and hygiene?
MARKET INDICATORS
Table 5 Birth Rates 2019-2024
Table 6 Infant Population 2019-2024
Table 7 Female Population by Age 2019-2024
Table 8 Total Population by Age 2019-2024
Table 9 Households 2019-2024
Table 10 Forecast Infant Population 2024-2029
Table 11 Forecast Female Population by Age 2024-2029
Table 12 Forecast Total Population by Age 2024-2029
Table 13 Forecast Households 2024-2029
MARKET DATA
Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2020-2024
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2021-2024
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2019-2024
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2019-2024
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2024
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2024-2029
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2024-2029
DISCLAIMER
SOURCES
Summary 1 Research Sources

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us